Bethesda Now – by Aaron KrautResearchers at the NIH campus in Bethesda say an experimental vaccine to prevent the Ebola virus was well-tolerated and produced immune system responses in the 20 adults part of the agency’s first clinical trial.
“Based on these positive results from the first human trial of this candidate vaccine, we are continuing our accelerated plan for larger trials to determine if the vaccine is efficacious in preventing Ebola infection,” said Dr. Anthony Fauci, director of NIH’s National Institute of Allergy and Infectious Diseases. “The unprecedented scale of the current Ebola outbreak in West Africa has intensified efforts to develop safe and effective vaccines, which may play a role in bringing this epidemic to an end and undoubtedly will be critically important in preventing future large outbreaks.”
The Ebola virus outbreak has resulted in more than 6,000 deaths, mainly in the western Africa nations of Liberia, Sierra Leone and Guinea.
The Bethesda-based federal agency has been key in this country’s response, testing possible vaccines and successfully treating a Dallas nurse who had contracted the virus from a patient there.
The trial included 20 volunteers between the ages of 18 and 50.
Ten volunteers received an intramuscular injection of vaccine at a lower dose and 10 received the same vaccine at a higher dose. At two weeks and four weeks following vaccination, the researchers tested the volunteers’ blood to determine if anti-Ebola antibodies were generated. All 20 volunteers developed such antibodies within four weeks of receiving the vaccine. Antibody levels were higher in those who received the higher dose vaccine.
The experimental NIAID/GSK vaccine did induce a T-cell response in many of the volunteers, including production of CD8 T cells, which may be an important part of immune protection against Ebola viruses. Four weeks after vaccination, CD8 T cells were detected in two volunteers who had received the lower dose vaccine and in seven of those who had received the higher dose.
Two people who received the higher dose vaccine did have a brief fever within a day of the vaccination, though NIH said no serious adverse effects were observed in trial volunteers.
A 39-year-old woman was the first volunteer to receive a dose of the experimental vaccine on Sept. 2 at the NIH Clinical Center.
The vaccine contains segments of Ebola virus genetic material, according to NIH, “that causes a common cold in chimpanzees but causes no illness in humans. The candidate vaccine does not contain Ebola virus and cannot cause Ebola virus disease.”
http://www.bethesdanow.com/2014/11/28/first-experimental-ebola-vaccine-appears-safe-nih-says/
So tomorrow apparently Obama is going to be making a big announcement about this wonderful Ebola vaccine and then pushing for more dollars to fight Ebola:
President Obama will visit the National Institutes of Health (NIH) Tuesday to praise doctors completing preliminary critical trials of an Ebola vaccine and to push members of Congress to quickly approve new funding to fight the virus the administration has requested.
Mr. Obama asked Congress to approve an extra $6.18 billion in emergency funding on November 5, the day after the midterm elections. In a letter to House Speaker John Boehner, R-Ohio, he said the money would be used for the U.S. efforts to fight the disease in West Africa, to improve domestic readiness against the disease and to speed up the testing for vaccines.
Read more: http://www.cbsnews.com/news/obama-to-push-congress-for-more-money-to-fight-ebola/
Yay. Another feral alphabet soup agency that saved us from something that you fictitiously created so you could suck more money out of the people and inject us with more poison? Good job.
They never rest, do they? This one will probably soon be mandatory for all ps kids too if not used for public health emergency to cull the herd.
“The unprecedented scale of the current Ebola outbreak in West Africa has intensified efforts to develop safe and effective vaccines,…”
BAHAHAHAHAHAHAHAHAHAHAHAHAHAHAHAHAHA!!!
No such thing.
Stop poisoning their water, and they’ll stop dying.